4//SEC Filing
IRONWOOD PHARMACEUTICALS INC 4
Accession 0001209191-17-039167
$IRWDCIK 0001446847operating
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:27 PM ET
Size
5.3 KB
Accession
0001209191-17-039167
Insider Transaction Report
Form 4
OLANOFF LAWRENCE S
Director
Transactions
- Sale
Class A Common Stock
2017-06-08$17.78/sh−3,200$56,896→ 35,330 total
Footnotes (2)
- [F1]This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.61 to $18.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001446847
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:27 PM ET
- Size
- 5.3 KB